Obama launches multi-strategy attack on antibiotic resistance
This article was originally published in Scrip
The White House on 18 September said it was serious about combating antimicrobial resistance (AMR) and issued three documents laying out a multi-strategy plan of attack, which officials said demonstrated President Barack Obama commitment of making the matter a top national priority.
You may also be interested in...
Upcoming White House report on antibiotic incentives will provide a strong endorsement of one-time payments to reward successful development of new therapeutics. That is a mixed blessing for advocates for legislative action for incentives who are focusing on 'wildcard' patents.
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.